Identifying new human oocyte marker genes: a microarray approach

被引:83
作者
Gasca, Stephan
Pellestor, Franck
Assou, Said
Loup, Vanessa
Anahory, Tal
Dechaud, Herve
De Vos, John
Hamamah, Samir
机构
[1] CHU Montpellier, Hop Arnaud de Villeneuve, Serv Biol & Med Reprod, Unite AMP DPI, F-34295 Montpellier 5, France
[2] CHU Montpellier, Hop St Eloi, Inst Rech Biotherapie, F-34295 Montpellier, France
[3] INSERM, U847, F-34197 Montpellier, France
[4] Univ Montpellier 1, UFR Med, F-34000 Montpellier, France
[5] Inst Human Genet, CNRS, UPR 1142, F-34396 Montpellier, France
[6] CHU Montpellier, Hop Arnaud de Villeneuve, Serv Gynecol Obstet, F-34295 Montpellier, France
关键词
cell cycle; cumulus-oocyte complex; marker genes; microarray;
D O I
10.1016/S1472-6483(10)60785-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The efficacy of classical IVF techniques is still impaired by poor implantation and pregnancy rates after embryo transfer. This is mainly due to a lack of reliable criteria for the selection of embryos with sufficient development potential. Several studies have provided evidence that some gene expression levels could be used as objective markers of oocyte and embryo competence and capacity to sustain a successful pregnancy. These analyses usually use reverse transcription-polymerase chain reaction to look at small sets of pre-selected genes. However, microarray approaches allow the identification of a wider range of cellular marker genes which could include additional and perhaps more suitable genes that could serve as embryo selection markers. Microarray screenings of around 30,000 genes on U133P Affymetrix(TM) gene chips made it possible to establish the expression profile of these genes as well as other related genes in human oocytes and cumulus cells. This study identifies new potential regulators and marker genes such as BARD1, RBL2, RBBP7, BUB3 or BUB1B, which are involved in oocyte maturation.
引用
收藏
页码:175 / 183
页数:9
相关论文
共 34 条
[1]   The human cumulus-oocyte complex gene-expression profile [J].
Assou, Said ;
Anahory, Tal ;
Pantesco, Veronique ;
Le Carrour, Tanguy ;
Pellestor, Franck ;
Klein, Bernard ;
Reyftmann, Lionel ;
Dechaud, Herve ;
De Vos, John ;
Hamamah, Samir .
HUMAN REPRODUCTION, 2006, 21 (07) :1705-1719
[2]   Expression profiles of individual human oocytes using microarray technology [J].
Bermúdez, M ;
Wells, D ;
Malter, H ;
Munné, S ;
Cohen, J ;
Steuerwald, NM .
REPRODUCTIVE BIOMEDICINE ONLINE, 2004, 8 (03) :325-337
[3]   Expression of cell adhesion molecules during human preimplantation embryo development [J].
Bloor, DJ ;
Metcalfe, AD ;
Rutherford, A ;
Brison, DR ;
Kimber, SJ .
MOLECULAR HUMAN REPRODUCTION, 2002, 8 (03) :237-245
[4]   A common set of gene regulatory networks links metabolism and growth inhibition [J].
Cam, H ;
Balciunaite, E ;
Blais, A ;
Spektor, A ;
Scarpulla, RC ;
Young, R ;
Kluger, Y ;
Dynlacht, BD .
MOLECULAR CELL, 2004, 16 (03) :399-411
[5]   MAD2B is an inhibitor of the anaphase-promoting complex [J].
Chen, J ;
Fang, GW .
GENES & DEVELOPMENT, 2001, 15 (14) :1765-1770
[6]   DEVELOPMENT OF THE RAT OOCYTE INVITRO - INHIBITION AND INDUCTION OF MATURATION IN THE PRESENCE OR ABSENCE OF THE CUMULUS OOPHORUS [J].
DEKEL, N ;
BEERS, WH .
DEVELOPMENTAL BIOLOGY, 1980, 75 (02) :247-254
[7]   Incomplete denudation of oocytes prior to ICSI enhances embryo quality and blastocyst development [J].
Ebner, T. ;
Moser, M. ;
Sommergruber, M. ;
Shebl, O. ;
Tews, G. .
HUMAN REPRODUCTION, 2006, 21 (11) :2972-2977
[8]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[9]   Paracrine actions of growth differentiation factor-9 in the mammalian ovary [J].
Elvin, JA ;
Clark, AT ;
Wang, P ;
Wolfman, NM ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (06) :1035-1048
[10]   BARD1 regulates BRCA1 apoptotic function by a mechanism involving nuclear retention [J].
Fabbro, M ;
Schuechner, S ;
Au, WWY ;
Henderson, BR .
EXPERIMENTAL CELL RESEARCH, 2004, 298 (02) :661-673